Effects of Respiratory Muscle Functions on Interstitial Lung Disease:

Status Completed

Clinical Trial Summary

Although there are numerous data demonstrating the impact of Interstitial Lung Disease (ILD) on respiratory functions, there is a lack of studies investigating the effects of respiratory functions on parameters such as sleep quality, dyspnea, and fatigue. The primary objective of the study is to examine the influence of changes in respiratory muscle functions in ILD on sleep quality, dyspnea, and fatigue parameters. The secondary objective is to investigate the effects of respiratory muscle functions in ILD on parameters such as cough, pain, exercise capacity, peripheral muscle strength, anxiety, depression, and quality of life.

Clinical Trial Description

Introduction: Despite having numerous data demonstrating the impact of Interstitial Airway Disease (IAD) on respiratory functions, there is a lack of studies investigating the effects of respiratory functions on parameters such as sleep quality, dyspnea, and fatigue. The primary objective of the study is to examine the effects of changes in respiratory muscle functions in IAD on sleep quality, dyspnea, and fatigue parameters. The secondary objective is to investigate the effects of respiratory muscle functions in IAD on parameters such as cough, pain, exercise capacity, peripheral muscle strength, anxiety, depression, and quality of life. Methods: Between June 2020 and June 2023, 36 volunteer participants aged 18 and above, who were receiving treatment in the Department of Chest Diseases at Istanbul University, Istanbul Faculty of Medicine, and met the inclusion criteria, were included in the project. Participants' respiratory function tests, respiratory muscle functions, dyspnea levels, cough, sleep quality, peripheral muscle strength, quality of life, exercise capacity, and fatigue levels were evaluated. Pearson Correlation Test was applied to determine the relationship between variables. Multiple linear regression analysis was used to examine factors that could affect respiratory muscle strength and endurance values. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05993520
Study type	Observational [Patient Registry]
Source	Istanbul University
Contact
Status	Completed
Phase
Start date	June 1, 2020
Completion date	June 1, 2023

View Details

See also
Status	Clinical Trial	Phase
Enrolling by invitation	`NCT04905693` - Extension Study of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis	Phase 3
Recruiting	`NCT05631132` - May Noninvasive Mechanical Ventilation (NIV) and/or Continuous Positive Airway Pressure (CPAP) Increase the Bronchoalveolar Lavage (BAL) Salvage in Patients With Pulmonary Diseases?	N/A
Recruiting	`NCT05417776` - Collagen-targeted PET Imaging for Early Interstitial Lung Disease	Phase 2
Not yet recruiting	`NCT04089826` - Long Term Oxygen Therapy in Patients With Interstitial Lung Disease
Recruiting	`NCT03467880` - Multicenter Study of Impulse Oscillometry in Chinese	N/A
Completed	`NCT00883129` - Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)	Phase 2
Completed	`NCT00362739` - Blood Collection From Individuals With Lung Disease for Genetic Studies	N/A
Recruiting	`NCT06133998` - Effects of Incentive Spirometry With and Without Aerobic Exercises in Interstitial Lung Disease	N/A
Active, not recruiting	`NCT03485378` - Assessment of Precision Irradiation in Early NSCLC and Interstitial Lung Disease	N/A
Recruiting	`NCT04098094` - Outcomes of RV Dysfunction in Acute Exacerbation of Chronic Respiratory Diseases
Recruiting	`NCT03400839` - Best Clinical Endpoints That Likely Induce Worse Prognosis in Interstitial Lung Diseases
Terminated	`NCT02633293` - An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE	Phase 2/Phase 3
Enrolling by invitation	`NCT05001009` - Goals of Care Conversations Study	N/A
Active, not recruiting	`NCT05068869` - Digital Outpatient Services	N/A
Active, not recruiting	`NCT03727568` - Study Comparing Two Different Methods of Cryobiopsy in the Interstitial Lung Diseases	N/A
Recruiting	`NCT06046547` - Integrating Palliative Care Education in Pulmonary Rehabilitation	N/A
Completed	`NCT04946708` - Virtual Exercise Program in Interstitial Lung Disease (ILD) Patients	N/A
Recruiting	`NCT04139356` - The Effect of Spontaneous Respiration on Pulse-oximetry Measurements	N/A
Recruiting	`NCT03726398` - CompRehensive Phenotypic Characterization of Patients With Scleroderma-Associated ILD and PH	Phase 2/Phase 3
Active, not recruiting	`NCT03295279` - WTC Chest CT Imaging Archive

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Effects of Respiratory Muscle Functions on Interstitial Lung Disease: Sleep Quality, Dyspnea, and Fatigue

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms